Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly – a randomised, double-blinded trial

BACKGROUND: Exercise testing in conjunction with measurement of cardiac biomarkers NT-proBNP and cTnI is a useful tool for monitoring the effect of treatment on cardiac patients. Administering Pimobendan in dogs with degenerative mitral valve disease (DMVD) and cardiomegaly results in delaying the o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Vet Res
Autores principales: Iwanuk, Nayeli, Nolte, Ingo, Wall, Leona, Sehn, Maximiliane, Raue, Jonathan, Pilgram, Anna, Rumstedt, Katja, Bach, Jan-Peter
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6617668/
https://ncbi.nlm.nih.gov/pubmed/31288807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-019-1980-z
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares